Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 26, 2015 - Issue 6
Submit an article Journal homepage
351
Views
3
CrossRef citations to date
0
Altmetric
Atopic Dermatitis & Urticaria

Long-term use of a 4% sodium cromoglicate cutaneous emulsion in the treatment of moderate to severe atopic dermatitis in children

Alan Martin EdwardsThe David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, UK, Correspondence[email protected]
,
Dalia BibawyThe David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, UK,
,
Sharon MatthewsThe David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, UK,
,
Nicky TongueThe David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, UK,
,
Syed Hasan ArshadThe David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, UK,
,
Karin Lødrup CarlsenDepartment of Paediatrics, Institute of Clinical Medicine, University of Oslo, Oslo, Norway,
,
Knut ØymarPediatric Department, Stavanger University Hospital, Stavanger, Norway,
,
Ian PollockDepartment of Paediatrics, Barnet and Chase Farm Hospitals NHS Trust, Barnet, Hertfordshire, UK,
,
Rollo CliffordChildren’s Centre, Dorset County Hospital, Dorchester, UK,
,
Anne ThomasDepartment of Dermatology, Cardiff University, Wales, UK, and
,
Rufaro GamanyaDepartment of Dermatology, Cardiff University, Wales, UK, and
,
Jui VyasDepartment of Dermatology, Cardiff University, Wales, UK, and
,
Michael T. StevensDepartment of Statistics, EmStat Ltd., Leicester, UK
&
Kai-Håkon CarlsenDepartment of Paediatrics, Institute of Clinical Medicine, University of Oslo, Oslo, Norway,
show all
Pages 541-547 | Received 11 Feb 2015, Accepted 19 Mar 2015, Published online: 24 Apr 2015

References

  • Kurukulaaratchy R, Fenn M, Matthews S, et al. The prevalence, characteristics of and early life risk factors for eczema in 10-year-old children. Pediatr Allergy Immunol. 2003;14:178–83
  • National Institute for Health and Care Excellence. [Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years]. [CG57]. London: National Institute for Health and Care Excellence, 2007
  • Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–18
  • Yang Y, Lu JY-L, Wu X, et al. G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. J Pharmacol. 2010;86:1–5
  • Edwards AM, Stevens MT, Church MK. The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial. BMC Research Notes. 2011;4:47 doi: 10.1186/1756-0500-4-47
  • Vieira Dos Santos R, Magerl M, Martus P, et al. Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol. 2010;162:674–6
  • Haider SA. Treatment of atopic eczema in children: a clinical trial of 10% SCG ointment. BMJ. 1977;1:1570–2
  • Thirumoothy T, Greaves MW. Disodium cromoglycate ointment in atopic eczema. BMJ. 1978;2:500–1
  • Croner S, Fagerlund I, Kjellman NI, et al. Sodium cromoglycate ointment in atopic eczema during childhood. Opuscula Medica. 1981;26:49–50
  • Kjellman NI, Gustafsson IM. Topical sodium cromoglycate in atopic dermatitis. A disappointing but informative trial. Allergy. 1986;41:423–8
  • Pike MG, Atherton DJ. Failure of a new topical sodium cromoglycate formulation to improve atopic dermatitis [letter]. Eur J Pediatr. 1988;148:170–2
  • Ariyanayagam M, Barlow TJ, Graham P, et al. Topical sodium cromoglycate in the management of atopic eczema–a controlled trial. Br J Dermatol. 1985;112:343–8
  • Kimata H, Igarashi M. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy. 1990;20:281–3
  • Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide. Eur J Pediatr. 1994;153:66–71
  • Hiratsuka S, Yoshida A, Ishioka C, Kimata H. Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis. J Allergy Clin Immunol. 1996;98:107–13
  • Stainer R, Matthews S, Arshad SH, et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (4% SCG emulsion), in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Brit J Dermatol. 2005;152:334–41
  • Berth-Jones J, Pollock I, Hearn RMR, et al. A randomised, controlled trial of 4% cutenous emulsion of sodium cromoglicate in the treatment of atopic dermatitis in children. J Dermatol Treat. 2014. [Epub ahead of print]. DOI: 10.3109/09546634.2014.933766
  • Stevens MT, Edwards AM. The effect of 4% sodium cromoglicate cutaneous emulsion compared to vehicle in atopic dermatitis in children – a meta-analysis of total SCORAD scores. J Dermatol Treat. 2014. [Epub ahead of print]. DOI: 10.3109/09546634.2014.933766
  • Williams HC, Burney PGJ, Pembroke AC, Hay RH. The UK working party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131:406–17
  • Staider JF, Taieb A. European Task Force on Atopic Dermatitis: severity scoring of atopic dermatitis: The SCORAD Index. Dermatology. 1993;186:23–31
  • Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol. 2001;144:104–10
  • Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942–9
  • Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines from the SCORAD index: consensus report of the European Task Force on atopic dermatitis. Dermatology. 1997;195:10–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.